How Much Does Zepbound Cost Without Insurance in 2026?

Short answer: through Eli Lilly’s own cash-pay program, $299 a month for the 2.5 mg starting dose, $399 for 5 mg, and $449 for 7.5 mg through 15 mg (verified 2026-09-14 on Lilly’s own coverage-and-savings pages) [1][2]. These are self-pay prices, and the $449 tier is a conditional purchase offer rather than a standing price. That is the same price whether you get the single-dose vial or the multi-dose KwikPen, and since March 2026 you can get the KwikPen price at most regular pharmacies instead of only by mail [3].

The number you will see quoted on older pages, roughly $1,000 to $1,100 a month, is the list price. It is real, but it is the price insurance claims get billed against, not the price a cash payer has to accept.

This guide walks every legal cash route, what each one actually costs today, and the conditions attached to the cheapest one. It is information, not medical advice. Whether Zepbound is right for you, and at what dose, is a conversation for you and a healthcare provider.

What is Zepbound’s list price in 2026?

Lilly’s own consumer pricing page states that the list price of Zepbound is $499 to $1,086.37 per fill, with a fill defined as a 28-day supply [1]. The wholesale acquisition cost figure is sourced to AnalySource as of January 1, 2026.

That range confuses people, so here is what it means. The single-dose pen, the presentation used when billing commercial insurance, carries the higher list price of $1,086.37. The vial presentation carries a much lower list price. Zepbound launched in November 2023 at $1,059.87 per fill, so the list price has risen about 2.5% since launch [4].

One useful detail: the list price is the same at every dose. The 2.5 mg starter pen has the same list price as the 15 mg pen. That is not true of Lilly’s cash-pay prices, which do go up with dose.

What does Zepbound cost through LillyDirect?

LillyDirect is Lilly’s direct-to-patient pharmacy channel. Prices there for self-pay are:

Dose	Self-pay price per month	Format
2.5 mg	$299	Vial or KwikPen
5 mg	$399	Vial or KwikPen
7.5 mg	$449	Vial or KwikPen
10 mg	$449	Vial or KwikPen
12.5 mg	$449	Vial or KwikPen
15 mg	$449	Vial or KwikPen

A “month” means 28 days: four single-dose vials, or one KwikPen [2][5].

One cost these figures leave out: supplies. Lilly’s own LillyDirect page attaches “Needle and syringe purchase required” to every vial card and “Pen needle purchase required” to every KwikPen card, so budget a little above the headline price [2].

Two dates matter here. On December 1, 2025 Lilly cut the vial ladder from $349/$499/$499 to $299/$399/$449 [6][7]. On February 23, 2026 it extended those same prices to the newly approved KwikPen, which had previously been more expensive [8]. If a page you are reading quotes $349 or $499 for Zepbound vials, it is describing prices Lilly retired.

LillyDirect does not dispense the medicine itself. Lilly says it works with four licensed dispensing pharmacies: Amazon Pharmacy, Fuze Health, Gifthealth and Walmart Pharmacy, and that the price is the same whichever one fills your prescription [2].

What is the 45-day refill rule, and what does missing it cost?

This is the single most expensive piece of fine print in the program.

The $449 price on 7.5 mg and above is a purchase offer, not a standing price. Lilly applies it automatically on your first purchase of a 7.5 mg or higher strength, and then to keep it you must complete each refill within 45 days of the previous delivery [5].

A month of Zepbound is 28 days of medicine. Against a 45-day deadline, that gives you roughly 17 days of cushion, which sounds generous until a prescription renewal, a holiday, a travel week or a shipping delay eats it.

If you fall out of the program, the footnote on Lilly’s own LillyDirect Zepbound page states it directly: “Regular prices will apply if prescription is not refilled within 45 days ($499 for 7.5mg, $699 for 10mg, $699 for 12.5mg, and $699 for 15mg)” [2][5]. At 10 mg that is $250 more per month, or $3,000 a year, for a missed calendar reminder.

The $299 and $399 prices at 2.5 mg and 5 mg are standing prices and are not conditioned on the refill window [5].

Vial or KwikPen: which should you ask for?

On price, it no longer matters. Since February 2026 both cost the same [8].

What differs is how you inject:

• The single-dose vial arrives as four vials for the month. You draw each weekly dose into a syringe yourself. Syringes and needles are sold separately at checkout. Vials are available only through the LillyDirect self-pay channel, with free home delivery or free pickup at Walmart Pharmacy [2].
• The single-patient-use KwikPen is a prefilled multi-dose injector holding all four weekly doses in one device. You attach a new pen needle for each injection, and pen needles are sold separately [2]. The FDA approved the Zepbound KwikPen on January 20, 2026 and Lilly launched it February 23 [8].
• The single-dose pen is the presentation used when you are billing commercial insurance, and it is the one Lilly’s $25 savings card applies to.

That third point trips people up. If your prescription is written for the single-dose pen and you intend to pay cash, you will not land on $299. Ask your prescriber to specify the vial or the KwikPen for a self-pay fill.

Can I get the cash price at my local pharmacy?

Yes, for the KwikPen, and this changed recently.

On March 16, 2026 Lilly announced that self-pay pricing on the Zepbound KwikPen would be available at LillyDirect and major pharmacies nationwide, starting at $299 per month for 2.5 mg [3]. The mechanism is a new KwikPen Self-Pay Savings Card, available at zepbound.lilly.com/savings to all patients including those with no insurance at all. Lilly’s terms allow up to 11 fills per calendar year and the card expires December 31, 2026 [5].

Lilly is explicit that this card applies only to the KwikPen. It does not apply to single-dose vials or single-dose pens [3].

Amazon Pharmacy separately announced on March 9, 2026 that it carries the KwikPen at transparent cash pricing starting at $299 per month, with same-day delivery to more than half of US households [9].

What about GoodRx, SingleCare and other discount cards?

The picture here flipped in 2026 because Lilly’s own price became available at retail.

GoodRx lists the Zepbound KwikPen from $299.00 without insurance at CVS, Walgreens, Walmart, Costco, Target, Sam’s Club, Amazon and the Kroger-family chains, describing that as 50% off an average retail price of about $601 for the most common version (checked September 14, 2026) [10].

Read that carefully, because it is presentation-specific. GoodRx’s own cost analysis puts the average monthly retail price of Zepbound single-dose pens at about $1,294, against about $605 for KwikPens and vials [10]. The $299 is not GoodRx out-negotiating the market; it is Lilly’s self-pay price reaching retail through a coupon. Prices on these pages move week to week, so check the live figure rather than quoting this one.

SingleCare, which prices the brand single-dose pens rather than the self-pay presentations, lists Zepbound from $947.00 for four 2.5 mg pens against an average retail price of $1,496.80 [11].

Two rules apply to every discount card. They are used instead of insurance, never on top of it. And nothing you spend on them counts toward a deductible or an out-of-pocket maximum.

What does Zepbound cost on TrumpRx.gov?

TrumpRx.gov, the federal most-favored-nation price site, lists the Zepbound Vial and advertises up to 72% off. The page asks you to pick a strength and a ZIP code before it shows a number; at the 2.5 mg starting dose that is $299.00 against an original price of $1,087.00, a saving of $788.00 [12]. Higher strengths follow Lilly’s own $399 and $449 ladder, so “72% off” is the best case, not the typical case.

TrumpRx does not sell drugs. It displays the price and sends you to LillyDirect, which confirms eligibility and handles delivery. In practice you land on the same Lilly program at the same price, so TrumpRx is a price-comparison front door rather than a separate cheaper channel.

Medicare is explicit that discount programs including TrumpRx are not creditable coverage and that money spent there does not count toward Part D out-of-pocket limits.

What if I have insurance that does not cover Zepbound?

You have two separate options and they are easy to mix up.

Option one, the savings card’s non-covered tier. If you have commercial drug insurance that does not cover the Zepbound single-dose pen, Lilly’s card sets the price at as low as $499 per one-month fill of the single-dose pen, with savings calculated as wholesale acquisition cost minus $499 and capped at 13 fills per calendar year. The card expires December 31, 2026 [13].

Option two, just pay self-pay. Switch the prescription to the KwikPen or vial and use the $299/$399/$449 ladder instead. For most people this is cheaper.

Neither option is open to anyone on Medicare, Medicaid, Medigap, Medicare Advantage, TRICARE, VA or DoD coverage. Lilly’s terms exclude all government beneficiaries from the savings card programs [13]. Government beneficiaries can still buy at self-pay prices, but they must pay outside their coverage, and nothing counts toward Part D totals.

How much will a full year cost?

Because Zepbound is titrated up over the first few months, year one is cheaper than year two. Using Lilly’s current ladder and 13 fills of 28 days:

• Month 1 at 2.5 mg: $299
• Month 2 at 5 mg: $399
• Months 3 through 13 at 7.5 mg or above: 11 x $449 = $4,939
• Year one total: about $5,637

A steady year at $449 is about $5,837. That is the number to plan around if you stay on a maintenance dose, and it assumes you never miss the 45-day window.

If you do miss it repeatedly at 10 mg, the same year is 13 x $699, or about $9,087.

What about compounded tirzepatide?

Compounded tirzepatide is not the same product and is not a generic. It is not FDA-approved.

The FDA declared the tirzepatide injection shortage resolved on December 19, 2024, and the enforcement-discretion windows that allowed large-scale compounding closed on February 18, 2025 for 503A pharmacies and March 19, 2025 for 503B outsourcing facilities [14]. On April 1, 2026 the FDA restated that tirzepatide appears on neither the 503B bulks list nor the drug shortage list, and said it does not intend to act against a compounder that fills four or fewer prescriptions of an essentially-a-copy product in a calendar month [14]. On April 30, 2026 the agency proposed removing tirzepatide, semaglutide and liraglutide from the 503B bulks list entirely.

Advertised telehealth prices for compounded tirzepatide in 2026 run roughly $179 to $549 a month, most commonly $258 to $399. Those are marketing rates, not verified transaction data. And at $299 for Lilly’s own starting dose, the price gap that drove the compounded market has largely closed.

When will generic Zepbound arrive?

Not this decade, on the current patent record.

The core composition-of-matter patent on tirzepatide, US 9,474,780, expires May 13, 2036 on FDA’s own Orange Book tables for both tirzepatide products [15]. Lilly has layered further patents on top. Zepbound’s listing (NDA 217806) carries formulation and device patents to June 14, 2039 and July 22, 2039; Mounjaro’s listing (NDA 215866) carries one running to December 30, 2041 [15]. Tirzepatide’s New Chemical Entity exclusivity runs to May 13, 2027, and Zepbound’s sleep-apnea new-indication exclusivity to December 20, 2027.

Sandoz announced FDA acceptance of its generic tirzepatide applications on June 29, 2026, and Amneal with Adalvo on July 8, 2026. Both sets of filings are for the single-dose autoinjector, not the KwikPen or the vial. Acceptance for review is not approval, and even an approved generic cannot launch while the patents stand. Anyone telling you cheap generic tirzepatide is coming next year is guessing.

The practical summary

Route	Price per month	The catch
List price	$499 to $1,086.37 per fill; $1,086.37 is the single-dose pen	The billing anchor, not a cash price
LillyDirect self-pay, vial or KwikPen	$299 / $399 / $449 by dose	45-day refill rule above 5 mg
KwikPen at a retail pharmacy	Same $299 to $449	KwikPen only; card expires 12/31/2026
TrumpRx	$299 for the vial	Routes you to LillyDirect anyway
GoodRx coupon	$299 for the KwikPen at major chains	Instead of insurance, not on top; pens cost far more
SingleCare, brand pens	From about $947	Prices the single-dose pen, not self-pay
Savings card, plan does not cover	$499, single-dose pen	Commercial insurance required
Savings card, plan covers Zepbound	As little as $25	Caps at $100 per fill, $1,300 a year
Compounded tirzepatide	About $179 to $549 advertised	Not FDA-approved; legally narrowing

If you are paying cash and your goal is the lowest legal price for the real product, the answer in 2026 is Lilly’s own self-pay channel, and the thing that will cost you money is not which pharmacy you use but whether you refill on time.

Talk to a healthcare provider about whether Zepbound is appropriate for you, and talk to the pharmacy about which presentation your prescription specifies before you check out.

Sources

1. Eli Lilly, Zepbound Cost Information: https://pricinginfo.lilly.com/zepbound
2. LillyDirect, Zepbound: https://www.lilly.com/lillydirect/zepbound
3. Eli Lilly media statement, March 16, 2026: https://investor.lilly.com/news-releases/news-release-details/media-statement-zepbound-tirzepatide-kwikpen-now-available-self
4. CNBC, Eli Lilly cuts cash prices of Zepbound vials: https://www.cnbc.com/2025/12/01/eli-lilly-prices-zepbound-weight-loss-drug-vials.html
5. Zepbound coverage, affordability and savings (HCP): https://zepbound.lilly.com/hcp/coverage-savings
6. Eli Lilly, Lilly lowers the price of Zepbound single-dose vials: https://investor.lilly.com/news-releases/news-release-details/lilly-lowers-price-zepboundr-tirzepatide-single-dose-vials
7. Walmart and LillyDirect retail pickup announcement: https://corporate.walmart.com/news/2025/10/29/lillydirect-and-walmart-pharmacy-launch-first-retail-pick-up-option-with-direct-to-consumer-pricing-for-zepbound
8. Eli Lilly, Zepbound now available in multi-dose KwikPen: https://investor.lilly.com/news-releases/news-release-details/zepbound-tirzepatide-most-prescribed-weight-management
9. Amazon Pharmacy expands access to the Zepbound KwikPen: https://www.businesswire.com/news/home/20260309587894/en/Amazon-Pharmacy-Expands-Access-to-Eli-Lillys-Zepbound-KwikPen-for-Weight-Management
10. GoodRx, Zepbound prices and coupons: https://www.goodrx.com/zepbound
11. SingleCare, Zepbound coupons and prices: https://www.singlecare.com/prescription/zepbound
12. TrumpRx.gov, Zepbound Vial: https://trumprx.gov/p/zepbound
13. Zepbound savings and insurance options: https://zepbound.lilly.com/savings
14. FDA, FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize: https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
15. FDA Orange Book patent and exclusivity data for Zepbound (NDA 217806): https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=217806&Appl_type=N and for Mounjaro (NDA 215866): https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=215866&Appl_type=N